Search

Your search keyword '"Verhamme, P."' showing total 45 results

Search Constraints

Start Over You searched for: Author "Verhamme, P." Remove constraint Author: "Verhamme, P." Topic business Remove constraint Topic: business
45 results on '"Verhamme, P."'

Search Results

1. Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK

2. Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: The InShape II study

3. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

4. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

5. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

6. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

7. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

8. Predictors of active cancer thromboembolic outcomes

9. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE

10. Edoxaban for the treatment of cancer-associated venous thromboembolism

11. Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry

12. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism

13. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry

14. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

15. Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis

16. Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism

17. Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy

18. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

19. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

20. Fondaparinux in the initial and long-term treatment of venous thromboembolism

21. Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?

22. Oral rivaroxaban for symptomatic venous thromboembolism

23. Venous thromboembolism in patients immobilised at home

24. Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism

25. Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

26. Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients

27. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

28. Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study

29. A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

30. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

31. Association between reperfusion therapy and outcomes in patients with acute pulmonary embolism and right heart thrombi

32. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

33. Timing and characteristics of venous thromboembolism after noncancer surgery

34. Current management strategies and long‐term clinical outcomes of upper extremity venous thrombosis

35. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

36. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

37. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

38. Managing reversal of direct oral anticoagulants in emergency situations: Anticoagulation education task force white paper

39. DVT Management and Outcome Trends, 2001 to 2014

40. Inactive Matrix Gla Protein Is Causally Related to Adverse Health Outcomes: A Mendelian Randomization Study in a Flemish Population

41. Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice

42. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity

43. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

44. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs

45. Safety and Feasibility of a Diagnostic Algorithm Combining Clinical Probability,<scp>d</scp>-Dimer Testing, and Ultrasonography for Suspected Upper Extremity Deep Venous Thrombosis

Catalog

Books, media, physical & digital resources